NDC 0187-1950

CeraVe Healing

Petrolatum

CeraVe Healing is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Valeant Pharmaceuticals North America Llc. The primary component is Petrolatum.

Product ID0187-1950_1c87156d-4117-4570-a636-d3b7ed0d25b7
NDC0187-1950
Product TypeHuman Otc Drug
Proprietary NameCeraVe Healing
Generic NamePetrolatum
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2015-11-02
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart347
Labeler NameValeant Pharmaceuticals North America LLC
Substance NamePETROLATUM
Active Ingredient Strength47 g/100g
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0187-1950-40

2 TUBE in 1 CARTON (0187-1950-40) > 10 g in 1 TUBE
Marketing Start Date2015-11-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0187-1950-03 [00187195003]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

NDC 0187-1950-35 [00187195035]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

NDC 0187-1950-99 [00187195099]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

NDC 0187-1950-05 [00187195005]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

NDC 0187-1950-40 [00187195040]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

NDC 0187-1950-12 [00187195012]

CeraVe Healing OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-02
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
PETROLATUM46.5 g/100g

OpenFDA Data

SPL SET ID:323c4a33-a824-4297-b4df-b6ab33e24eb0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1728288
  • NDC Crossover Matching brand name "CeraVe Healing" or generic name "Petrolatum"

    NDCBrand NameGeneric Name
    0404-0375A and DPetrolatum
    0363-0941Advanced HealingPetrolatum
    0363-9247Advanced HealingPetrolatum
    0869-0247Advanced HealingPetrolatum
    0295-9062Allermi Skin SaviorPetrolatum
    0363-0731Baby PetroleumPetrolatum
    0295-1031Bag Balm First AidPetrolatum
    0187-1950CeraVePetrolatum
    0187-2487CeraVePetrolatum
    0299-4116Cetaphil Healingpetrolatum
    0573-1906ChapStick Classic CherryPETROLATUM
    0573-1901ChapStick Classic OriginalPETROLATUM
    0573-1912ChapStick Classic SpearmintPETROLATUM
    0573-1916ChapStick Classic StrawberryPETROLATUM
    0573-1945CHAPSTICK FLAVA CRAZEpetrolatum
    0295-4271ILEX Skin ProtectantPetrolatum
    0404-0042Petrolatumpetrolatum
    0869-0180PetrolatumPetrolatum
    0536-1143Rugby Petrolatum HydratingPetrolatum
    0363-0079Walgreens Baby HealingPetrolatum
    0363-3300WELL AT WALGREENSPETROLATUM

    Trademark Results [CeraVe]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CERAVE
    CERAVE
    98843091 not registered Live/Pending
    Yan Run
    2024-11-08
    CERAVE
    CERAVE
    98765114 not registered Live/Pending
    Du, Ting
    2024-09-23
    CERAVE
    CERAVE
    98733953 not registered Live/Pending
    Haijiang Wang
    2024-09-05
    CERAVE
    CERAVE
    98428743 not registered Live/Pending
    Zheng, XiaoLi
    2024-03-01
    CERAVE
    CERAVE
    97255760 not registered Live/Pending
    L'Oreal USA Creative, Inc.
    2022-02-07
    CERAVE
    CERAVE
    78519354 3234519 Live/Registered
    L'Oreal USA Creative, Inc.
    2004-11-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.